SÉZARY

Clinical trials for SÉZARY explained in plain language.

Never miss a new study

Get alerted when new SÉZARY trials appear

Sign up with your email to follow new studies for SÉZARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo targets rare skin cancer in small trial

Disease control Ongoing

This study tests whether combining pembrolizumab (an immunotherapy) with gemcitabine (a chemotherapy drug) can shrink tumors in people with advanced mycosis fungoides or Sézary syndrome, rare types of skin lymphoma. The trial enrolled 14 adults who had already tried at least one …

Matched conditions: SÉZARY

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

SÉZARY

Get alerted when new SÉZARY trials appear

New drug combo targets rare skin cancer in small trial